 |
 |
|
|
|
 |
|
|
|
 |
 |
|
|
01/17/2006
-- --
|
|
BETHESDA, Md., Jan. 17 /PRNewswire/ -- United BioSource Corporation (UBC)
today announced the acquisition of MetaWorks, Inc., a leading provider of
systematic reviews and meta-analyses to inform development, marketing, and
regulatory decision-making regarding health care products and services. The
acquisition is part of the UBC strategy of building integrated capabilities to
meet growing demand by the pharmaceutical, biotech, medical device and
diagnostics sectors for evidence-based product development and
commercialization services.
MetaWorks, Inc., provides an array of clinical data products and
scientific consulting services to aid the development and commercialization of
drugs, devices, diagnostics, and procedures. The company is a world leader in
systematic literature reviews of clinical data and the application of complex
statistical methods, such as meta-analysis. MetaWorks' database assets
include MetaHub(TM), a proprietary warehouse of formatted, synthesized, and
appraised clinical trial data. MetaWorks is a privately held company and
currently serves more than 75 clients in the life sciences industry.
UBC delivers evidence-based services to enhance the medical and commercial
potential of pharmaceuticals, biotechnology, medical devices and diagnostics.
The company leverages a unique suite of scientific capabilities to demonstrate
product effectiveness and safety, manage and minimize risk, document economic
value, and secure appropriate third-party payment for prescription medicines
and other medical technology.
"MetaWorks' scientific capabilities are on the forefront of decision-
making in biopharmaceutical product development and commercialization," said
UBC founder and CEO Ethan Leder. "Systematic literature reviews and meta-
analyses help drug researchers identify precise scientific objectives before
investing in costly clinical trials to test their hypotheses."
"UBC gives us the expanded reach, additional resources, and expertise we
need to meet the growing demand for our analytic and consulting services and
data products," said Shubh Sethi, MetaWorks President and CEO. Susan Ross,
MD, MetaWorks' scientific co-founder, added, "By joining forces with UBC, we
can take the pursuit of our mission -- harnessing the power of data for health
care -- to a higher level than ever before."
The addition of MetaWorks is the latest in a series of acquisitions
announced since UBC raised $153 million in equity capital from a syndicate of
leading private equity firms. MetaWorks will join UBC's Health Care Analytics
Group, formerly MEDTAP International, the company's team of world-recognized
research scientists. The MetaWorks management team will assume leadership
roles within UBC's Health Care Analytics Group. MetaWorks' operations will
remain headquartered in Medford, MA.
About UBC
United BioSource Corporation (UBC) delivers evidence-based solutions to
enhance the medical and commercial potential of pharmaceuticals,
biotechnology, medical devices, and diagnostics. UBC is based in Bethesda,
Maryland. For more information, visit http://www.unitedbiosource.com or call
240-644-0420.
About MetaWorks
MetaWorks(R), Inc. is an evidence-based consulting company focused on
product development and commercialization within the biopharmaceutical,
device, and health care industries. MetaWorks, Inc. is based in Medford,
Massachusetts. For more information, visit http://www.metaworksinc.com.
SOURCE United BioSource Corporation
Web Site: http://www.unitedbiosource.com
http://www.metaworksinc.com
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
